Head of Research, Krungthai XSpring

Waraporn Wiboonkanarak

Head of Research

A full service Thai brokerage

Krungthai XSpring

Krungthai XSpring is a full service broker. The company provides a wide range of investment services such as Securities Brokerage, Derivative Agent Business, Securities Borrowing and Lending, Securities Trading, Underwriting, Financial Advisory, Wealth Advisory, Private Fund Management and International Markets Securities Trading. 

In terms of credibility, Fitch Ratings has assigned Krunghtai XSpring a long-term rating of AA- and a national short-term rating of F1+ with stable outlook.

Thematic (Sector/Industry)

<ul><li>Asian bourses rebounded ahead of the Fed meeting, where a rate cut is widely expected. Likewise, the SET gained support from anticipation of the government’s policy statement and stimulus measures.</li><li>The index successfully breached the 1,300-point resistance with rising trading volume and a strengthening baht, signaling further fund inflows that could drive the market higher toward a short-term target of 1,341 points.</li><li>We recommend selective speculation, as the index remains in a sustained uptrend.</li></ul>

Asian bourses rebounded ahead of the Fed meeting, where a rate cut is widely expected. Likewise, the SET gained support from anticipation of the government’s policy statement and stimulus measures.The index successfully breached the 1,300-point resistance with rising trading volume and a strengthening baht, signaling further fund inflows that could drive the market higher toward a short-term target of 1,341 points.We recommend selective speculation, as the index remains in a sustained uptrend.

Krungthai XSpring Technical Eng. September 17, 2025

<ul><li>Asian bourses advanced on expectations that the Fed will cut interest rates at its September 16–17 meeting.</li><li>The SET surged for a fifth consecutive day while gains in the electronic, transportation, finance and tourism sectors boosted the index up and finally increased 2.28% from the previous week.</li><li>Therefore, we continue to recommend selective speculation, as the index remains in the uptrend with having a bullish signal.</li></ul>

Asian bourses advanced on expectations that the Fed will cut interest rates at its September 16–17 meeting.The SET surged for a fifth consecutive day while gains in the electronic, transportation, finance and tourism sectors boosted the index up and finally increased 2.28% from the previous week.Therefore, we continue to recommend selective speculation, as the index remains in the uptrend with having a bullish signal.

Krungthai XSpring Technical Eng. September 15, 2025

CEO, A. Stotz Investment Research

Dr. Andrew Stotz, CFA

Quantamental Investing to beat Benchmarks

A. Stotz Investment Research

We pick stocks. We construct portfolios. All our effort is focused on how to better pick stocks and construct portfolios. We serve fund management companies, family offices, and high net worth individuals.

<ul>
<li>We highlight 14 stocks in Thailand that look interesting to us based on our FVMR Methodology</li>
<li>Portfolio changes: 10 stocks remain, four new join the fray</li>
<li>Since inception, it has gained 75% versus the SET 100 Index’s return of 20%</li>
</ul>


We highlight 14 stocks in Thailand that look interesting to us based on our FVMR Methodology
Portfolio changes: 10 stocks remain, four new join the fray
Since inception, it has gained 75% versus the SET 100 Index’s return of 20%


The Stocks to Own in Thailand – Vol. 50

Global Healthcare Analyst

Tina Banerjee

Equity Bottom-Up

Bangkok Dusit Medical Services / Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/bangkok-dusit-medical-services-pcl" target="_blank" data-smartkarma-citation="entities:875:1" rel="noopener">Bangkok Dusit Medical Services (BDMS TB)</a> posted 4% rise in revenue from hospital operations in 2Q25 as international and Thai patients revenue reported growth of 6% and 3% YoY, respectively.</li>
<li>EBITDA grew 7% YoY to THB 6.1B on higher revenue and better cost management, while net profit rose 5% YoY to THB 3.5B on lower interest cost. Margins expanded.</li>
<li>BDMS has delivered an overall stable financial performance with inpatient revenue growth and stable EBITDA margin. Near term upside potential remains.</li>
</ul>



Bangkok Dusit Medical Services (BDMS TB) posted 4% rise in revenue from hospital operations in 2Q25 as international and Thai patients revenue reported growth of 6% and 3% YoY, respectively.
EBITDA grew 7% YoY to THB 6.1B on higher revenue and better cost management, while net profit rose 5% YoY to THB 3.5B on lower interest cost. Margins expanded.
BDMS has delivered an overall stable financial performance with inpatient revenue growth and stable EBITDA margin. Near term upside potential remains.


Bangkok Dusit (BDMS TB): Revenue Rise in 2Q25; Margins Expand; Stable Outlook To Bring in Returns

<ul><li>The SET Index is expected to weaken today, with the support at 1,253/1,250 points (10-day EMA) and the resistance at 1,270/1,280 points.</li><li>US Producer Price Index (PPI) in July rose 0.9% MoM and 3.3% YoY (market expected +0.2% MoM / +2.5% YoY), marking the highest increase since March 2022, mainly driven by higher service costs.</li><li>Thai listed companies that have reported 2Q25 earnings account for 94.3% of total market capitalization (considering only stocks with Bloomberg consensus).</li></ul>

The SET Index is expected to weaken today, with the support at 1,253/1,250 points (10-day EMA) and the resistance at 1,270/1,280 points.US Producer Price Index (PPI) in July rose 0.9% MoM and 3.3% YoY (market expected +0.2% MoM / +2.5% YoY), marking the highest increase since March 2022, mainly driven by higher service costs.Thai listed companies that have reported 2Q25 earnings account for 94.3% of total market capitalization (considering only stocks with Bloomberg consensus).

Krungthai XSpring Zoom Eng. August 15, 2025.

Thailand

Bangkok Chain Hospital Public Company Limited operates a chain of hospitals in Thailand serving both the cash and managed care markets.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Bangkok Chain Hospital (BCH TB)

Krungthai XSpring Technical Eng. September 17, 2025

Asian bourses rebounded ahead of the Fed meeting, where a rate cut is widely expected. Likewise, the SET gained support from anticipation of the...

Krungthai XSpring

Krungthai XSpring Technical Eng. September 15, 2025

The SET surged for a fifth consecutive day while gains in the electronic, transportation, finance and tourism sectors boosted the index up and...

Krungthai XSpring

The Stocks to Own in Thailand – Vol. 50

We highlight 14 stocks in Thailand that look interesting to us based on our FVMR Methodology. Portfolio changes: 10 stocks remain, four new join...

A. Stotz Investment Research

Bangkok Dusit (BDMS TB): Revenue Rise in 2Q25; Margins Expand; Stable Outlook To Bring in Returns

Bangkok Dusit Medical sees 4% revenue rise in 2Q25, mainly driven by international patients revenue, while EBITDA and net profit margin expanded...

Tina Banerjee

Krungthai XSpring Zoom Eng. August 15, 2025.

The SET Index is expected to weaken today, with the support at 1,253/1,250 points (10-day EMA) and the resistance at 1,270/1,280 points.

Krungthai XSpring

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Krungthai XSpring Technical Eng. September 17, 2025

Asian bourses rebounded ahead of the Fed meeting, where a rate cut is widely expected. Likewise, the SET gained support from anticipation of the...

Krungthai XSpring

Krungthai XSpring Technical Eng. September 15, 2025

The SET surged for a fifth consecutive day while gains in the electronic, transportation, finance and tourism sectors boosted the index up and...

Krungthai XSpring

The Stocks to Own in Thailand – Vol. 50

We highlight 14 stocks in Thailand that look interesting to us based on our FVMR Methodology. Portfolio changes: 10 stocks remain, four new join...

A. Stotz Investment Research

Bangkok Dusit (BDMS TB): Revenue Rise in 2Q25; Margins Expand; Stable Outlook To Bring in Returns

​Bangkok Dusit Medical sees 4% revenue rise in 2Q25, mainly driven by international patients revenue, while EBITDA and net profit margin expanded...

Tina Banerjee

Krungthai XSpring Zoom Eng. August 15, 2025.

The SET Index is expected to weaken today, with the support at 1,253/1,250 points (10-day EMA) and the resistance at 1,270/1,280 points.

Krungthai XSpring

Bangkok Dusit Medical sees 4% revenue rise in 2Q25, mainly driven by international patients revenue, while EBITDA and net profit margin expanded...